Navigation Links
Genomic Health Announces Second Quarter 2008 Financial Results and Business Progress
Date:8/5/2008

o Group Health Incorporated and HIP Health Plan of New York established

policies covering approximately 4.6 million lives.

Product Pipeline

Breast Cancer

-- Targeting inclusion of quantitative HER2 scores in all Oncotype DX

reports by the end of 2008.

-- Conducting a study using Oncotype DX in breast cancer patients treated

with aromatase inhibitors with the goal of reporting results this year.

Colon Cancer

-- Received first trial specimens for our clinical validation study, which

we expect to begin in the second half of 2008.

-- Received milestone payment from Bristol-Myers Squibb related to Genomic

Health's program to identify genes to predict response to cetuximab

(Erbitux(R)).

Other Cancers

-- Established collaborators and identified sources of clinical samples

to further our prostate and lung cancer programs.

-- Began gene identification work to develop a prognostic test for

patients with renal cell carcinoma, clear cell type, under the Pfizer

collaboration announced in January of 2008.

International

-- Initiated a study supporting Japanese investigators as they gain

clinical experience with Oncotype DX for early-stage breast cancer

patients.

-- Processing samples from patients in Canada, Ireland and Peru enrolled

in the National Cancer Institute-sponsored TAILORx study, which has

expanded internationally.

Conference Call Details

To access the live conference call today, August 5, at 4:30 p.m. Eastern Time via phone, please dial (877) 356-8064 from the United States and Canada or (706) 758-4314 internationally. The conference ID is 56195752. Please dial in approximately ten minutes prior to the start of the call. A telephone replay will be available beginning approximately one hour after the call through August 12 and may be accessed by dialing (
'/>"/>

SOURCE Genomic Health, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7 8 9 10

Related biology technology :

1. Transgenomic, Inc. Reports Second Quarter 2007 Results
2. Rosetta Genomics Announces Annual General Meeting of Shareholders to be Held on September 24, 2007
3. GeneNews Chief Scientist Dr. C.C. Liew co-editor of new genomics reference book
4. CODA Genomics Announces Issuance of Optimized Synthetic Gene Production Patent
5. Revolutionary Genomics Research Group Opens Boston Office; Provides DNA Evidence in Workers Comp Cases
6. WallSt.net (www.wallst.net) Announces Upcoming Interview With CEO of DNAPrint Genomics
7. NYU Medical Center Collaborates With Rosetta Genomics to Develop a microRNA-Based Diagnostic Test for Melanoma
8. Rosetta Genomics to Present at the American Association of Cancer Research (AACR) "Molecular Diagnostics in Cancer Therapeutic Development" Conference
9. Rosetta Genomics to Webcast Presentation at Maxim Group Growth Conference
10. BioNanoatrix and Complete Genomics Receive $8.8 Million NIST-ATP Award to Develop Sequencing Platform for $100 Genome
11. BioNanomatrix and Complete Genomics Receive $8.8 Million NIST-ATP Award to Develop Sequencing Platform for $100 Genome
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/24/2013)... Many factors impact tissues targeting such as ... at the blood-tissue barrier. Even when tissue disposition is ... the tissue rather than the total tissue concentration. , ... to guide lead optimization, predict in vivo activity in ... may impact the likely human clinical dose. , In ...
(Date:5/24/2013)... WI (PRWEB) May 24, 2013 ... the discovery and development of calcium-binding proteins to ... of safety assessment study of apoaequorin ... international journal published for the British Industrial Biological ... study was to investigate potential adverse effects, if ...
(Date:5/23/2013)... 2013 Venaxis, Inc. (Nasdaq:   APPY), an ... FDA clearance and commercializing its rapid, protein biomarker-based appendicitis ... an underwritten public offering of 10,000,000 shares of its ... of its common stock at an exercise price of ... of $1.25 per share and related warrant.  Venaxis has ...
(Date:5/23/2013)... 23, 2013 Graphite Metallizing Corporation ... bushings mounted in stainless steel pillow blocks. This ... GRAPHALLOY with the application and installation versatility of ... Blocks work exceptionally well when submerged in ... liquids such as acids, alkalies, hydrocarbons, black liquor, ...
Breaking Biology Technology:DMPK for Targeted Tissue Delivery: Solutions for the Most Challenging Part of Outsourcing, New Life Science Webinar Hosted by Xtalks 2Safety Assessment Study of Apoaequorin Published in Food and Chemical Toxicology 2Venaxis Announces Pricing of Offering of Common Stock and Warrants 2Venaxis Announces Pricing of Offering of Common Stock and Warrants 3Graphite Metallizing Now Offers GRAPHALLOY® Stainless Steel Pillow Blocks for Success in Submersible Applications 2Graphite Metallizing Now Offers GRAPHALLOY® Stainless Steel Pillow Blocks for Success in Submersible Applications 3
... Nov. 8 Kosan Biosciences,Incorporated (Nasdaq: KOSN ) today ... 30, 2007. Net loss for the quarter and nine ... or $0.26 per share and $0.46 per share,compared to a ... and,$0.76 per share, in the same periods last year. ...
... and the Aflac Cancer Center for ... against pediatric cancer., COLUMBUS, Ga., Nov. 8 Last ... and the Aflac Cancer Center and,Blood Disorders Service at Children,s ... Corporate Citizenship Award. During a,prestigious ceremony hosted by television personality, ...
... Inc. (Nasdaq: MGRM ) announced today that William ... corporate overview at the Piper,Jaffray 19th Annual Healthcare Conference ... at the Pierre Hotel in New York. To ... log on to http://www.monogrambio.com and go to ...
Cached Biology Technology:Kosan Announces Third Quarter 2007 Financial Results 2Kosan Announces Third Quarter 2007 Financial Results 3Kosan Announces Third Quarter 2007 Financial Results 4Kosan Announces Third Quarter 2007 Financial Results 5Kosan Announces Third Quarter 2007 Financial Results 6Kosan Announces Third Quarter 2007 Financial Results 7Aflac Honored with Corporate Citizenship Award 2Aflac Honored with Corporate Citizenship Award 3Monogram Biosciences to Present at the Piper Jaffray 19th Annual Healthcare Conference 2
(Date:5/22/2013)... have developed a novel technique that can detect molecular ... that is one of the most important, though time-consuming, ... a paper in Nature , post-doctoral researcher David ... Schnell of the Center for Free-Electron Laser Science (CFEL) ... finely-tuned microwave fields to identify molecular variants apart, and ...
(Date:5/22/2013)... Bethesda, Md. (May 22, 2013)The omega 3 fatty acids ... against cardiovascular diseaseso much so that the American Heart ... fish a week, particularly fatty varieties rich in omega ... remains a mystery. In a new study, scientists led ... light on this phenomenon by providing evidence that fish ...
(Date:5/22/2013)... The discovery of potential environmental and human health ... batteries each year has led scientists to recommend ... reuse of lithium-ion (Li-ion) battery materials. That,s the ... journal Environmental Science & Technology . , ... Li-ion batteries have become mainstays for powering everything ...
Breaking Biology News(10 mins):Detecting mirror molecules 2Detecting mirror molecules 3Fish oil may help the heart beat mental stress 2
... more than a breath freshener it could spot head ... Cancer Center. Their new study of a mouth rinse ... for screening those at high risk, including heavy smokers and ... at Johns Hopkins asked 211 head and neck cancer patients ...
... In the January 1st issue of G&D, Drs. Thomas ... into the degradation of mammalian histone,mRNA. Histone mRNA ... but the,mechanism by which this occurs has remained elusive, ... structure rather than the,canonical 3, poly(A) tail. Drs. ...
... -- A research team at Weill Cornell Medical College in ... crucial to the production of an immune system cytokine called ... important "missing link" in a biochemical pathway that,s long been ... to cancer and AIDS. "IL-10 production has to be ...
Cached Biology News:'Swish-and-spit' test accurate for cancer 22 genes are important key to regulating immune response 22 genes are important key to regulating immune response 3
With L-glutamine and potassium bicarbonate. Sterile, Insect cell culture tested...
Matrix for protein MALDI-MS...
A set of five proteins which can be used to calibrate a Matrix-assisted laser desorption/ionization time-of-flight (MALDI-TOF) or Electrospray Ionization (ESI) mass spectrometer....
... of Grace's medium were developed in several ... Many of these modifications were developed by ... cells derived from the cabbage looper,Tricoplusia ni. ... TNM-FH. The medium when properly supplemented has ...
Biology Products: